Several BCS1L gene mutations have been reported in CIII deficiency, associated with different clinical presentations ranging from multisystem involvement including neonatal proximal tubulopathy, hepatopathy, and encephalopathy, to isolated neurological syndrome with long-term survival [67–69]. This evidence concerns the gene BCS1L and hyperinsulinemic hypoglycemia, familial, 4.